Tuesday, May 24, 2016 Keynote speakers
President, GMPO Orphan Therapeutics, USA
Senior Managing Director , Evercore Partners, USA
President and CEO of Genetic Alliance, USA
Tuesday, May 24, 2016 The Promise of Immuno-Oncology Hall A
Chief Scientist, Sheba Medical Center, Israel
President and CEO, Founder, Chairman, Board of Directors, Kite Pharma, USA
Vice-President, Immunoscience, Bristol-Myers Squibb, USA
Founder, President and CEO, Adicet Bio, USA
Head of Molecular Immunology Lab, Technion, Israel
Head, Oncology External Innovation, Strategy, Science Policy & External Innovation, Sanofi, France
President and CEO, Compugen Ltd. Israel
Tuesday, May 24, 2016 Neurological Disorders Hall B
Vice President and Global Head, External R&D Innovation, BioTherapeutics and Strategic Investments, Worldwide Research & Development, Pfizer, Inc. USA
Chief Scientific Officer, Dementia Discovery Fund, Japan
Executive Vice President and Chief Strategy Officer, AbbVie, USA
Senior Director Quantitative Medicine | Neuroscience and Pain Research Unit Pfizer Inc. USA
Professor of Neuroimmunology, Department of Neurobiology, The Weizmann Institute of Science, Israel
Executive Director at Israel Brain Technologies, Israel
Associate Professor of Medical Neurobiology and Cognitive Siences, The Hebew University of Jerusalem, Israel
Tuesday, May 24, 2016 Early Stage Challenges and Opportunities Hall C
CEO, Sanara Ventures Ltd., Israel
CEO, Connected Care & Health Informatics, Philips, The Netherlands
CEO and Founder, OurCrowd, Israel
Chair, Mayo Clinic Ventures, USA
Partner, Paul Hastings (Europe)
GM of Early Stage Companies and Incubators, Israel Innovation Authority, Israel
Founder, Borderless Healthcare Group, Singapore
CEO, Sweetch, Israel
Divisional Vice President, Venture Investments, Abbott Ventures , USA
CEO, Medasense Biometrics Ltd, Israel
CEO, Kytera Technologies, Israel
Director of ReAbility Tele-Rehab Technologies at Gertner Institute, Israel
Vice President and Chief Innovation Officer, Henry Ford Health System, USA
CEO of The Henry Ford Innovation Institute and also serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Hospital in Detroit, USA
Associate Professor of Emergency Medicine, Chair of Emergency Tel Aviv Medical Center, Israel
CEO, Earlysense, Israel
CEO, Teva Israel & Head of Innovation Growth Markets, Israel
Chairman of GIBF (Global Independent Baptist Fellowship), Israel
Chief Biologist, Biopmedical, Israel
Head of Innovation Technologies and Services Teva, Israel
CEO, Circ MedTech, Israel
CEO, Philips Israel
Chief Science Officer & VP Business Development, Sight Diagnostic, Israel
Head of Israel’s leading private hospital Hertzeliya Medical Center, Israel
Chief Medical Officer of Clalit Healthcare Services, Israel
Wednesday, May 25, 2016 Keynote Speakers
Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies , USA
Wednesday, May 25, 2016 Personalized Diagnostics and Precision Medicine Hall A
Co-founder and CEO, MeMed, Israel
Professor of Oncology, Mayo Clinic, USA
Senior Executive/Board Director/Entrepreneur in Residence, USA
Global Head Diagnostics Biomarkers, Hoffmann-la Roche, Switzerland
President, GMPO Orphan, USA
Wednesday, May 25, 2016 Listen to Your Aching Heart Hall B
CEO, BioControl, Israel
Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development, Edwards Lifesciences, USA
Prof. of Medicine, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, USA
Vice President, Head of Cardiovascular and Fibrosis, Sanofi, USA
Wednesday, May 25, 2016 From Academia Research to Industry Hall C
CEO, Ramot at Tel Aviv University Ltd., Israel
Chairman, Hadassah Hospital and Hadasit, the Technology Transfer Company of Hadassah Medical Organization, Israel
Steba Biotech Ltd., Israel
CEO, Yeda, Israel
Director, Health Policy Planning & Director, Clalit Research Institute, Clalit Health Services, Israel
Department of Immunology – Faculty of Biology,Weizmann, Israel
Founding Partner, LionBird, Israel
CEO, Hadasit, Israel
Head of Hadassah’s Center for Melanoma and Immunotherapy, Israel
Faculty of Medicine, Bar Ilan University, Israel
Cell Research and Immunology,Tel Aviv University, Israel
Manager, Sheba Medical Center Technology Transfer Company, Israel
Head of the Brain Stimulation and Behavior lab, Ben Gurion University, Israel
CEO, Avraham Pharmaceuticals, Israel
Director of the department of Neurological Rehabilitation, Sheba Medical Center, Israel
VP, Motorika Ltd., Israel
CEO, Yissum Research Development Company of the Hebrew University of Jerusalem, Israel
Sheba Medical Center, Israel
Thursday, May 26, 2016 Keynote Speakers
Chief Scientist, Ministry of Economy, Israel
Global Leader for Health, PwC, UK
Vice President, Science and Solutions, IBM Research, T.J. Watson Research Center, USA
Thursday, May 26, 2016 Health IT Hall A
Director, Health Infomatics, IBM Research, Israel
Executive Vice President Statens Serum Institut, Division of Epidemiology and Disease Surveillance & The Danish National Biobank, Denmark
Offering Manager for Exogenous Data at IBM Watson Health, USA
President, Nutrino, Israel
VP, Head of Business Development & Connected Value Propositions, Philips, The Netherlands
General Manager of the Imaging Clinical Applications (ICAP), Philips Health Systems, Israel
VP Partnerships at Medisafe, Israel
Co-Founder and Chairman of Zebra Medical Vision, Israel
Thursday, May 26, 2016 The New “Kids” on the Block: Gene Editing and Gene Therapy Hall B
Co-Founder and CSO, LogicBio Therapeautics, Israel
Head of Specialty Pharmaceuticals Search & Evaluation, Business Development at Bristol-Myers Squibb, USA
Thursday, May 26, 2016 The New “Kids” on the Block: Microbiome Hall B
Professor of Medicine, Division of Gastroenterology, Rabin Medical Center (RMC), Beilinson Hospital, Israel
Director, Tel Aviv Sourasky Medical Center, Israel
Head of Bacteriotherapy Clinic, Department of Gastroenterology and Hepatology, Tel Aviv Medical Center, Israel
Chairman and Co-Founder, Rebiotix, USA
Global Program Head, Strategic Partnership Team, Novartis, Switzerland
Thursday, May 26, 2016 Robotics’ Role in Healthcare Hall C
Technion, Israel Institute of Technology, Israel
Vice President, Medical Devices, J&J, Therapeutic Area Expert in Robotics and MIS, USA
CEO & Company Group Chairman at MEDX Ventures Group, USA
Professor of Surgery, Harvard Medical School
Associate in Cardiac Surgery, Brigham & Women’s Hospital
Chief, Department of Cardiothoracic Surgery, Veterans Affairs Boston Healthcare System, USA
Associate in Cardiac Surgery, Brigham & Women’s Hospital
Chief, Department of Cardiothoracic Surgery, Veterans Affairs Boston Healthcare System, USA
Senior Director of Medical Research, Intuitive Surgical, USA
Senior Physician at the Department of Geriatric Medicine and Rehabilitation of the Hadassah-Hebrew University Medical Centers, Israel
CEO, Mazor Robotics Ltd, Israel
Professor at the Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Israel